Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IBM Watson Exec Eyes Oncology Advisors Pilot

This article was originally published in The Gray Sheet

Executive Summary

Dan Cerutti, general manager of IBM Watson commercialization, offered a status update June 5 on a health care application for the computer technology.

You may also be interested in...

Watson, M.D.: How IBM And Cleveland Clinic Are Working To Reboot Health Care With Supercomputing

IBM is working with Cleveland Clinic to bring Watson, the supercomputer “Jeopardy!” winner, to health care to change the way clinical decisions are made.

Digital Health In Brief

The latest news on remote patient monitoring, clinical decision support technology and wireless medical devices.

Latest Senate FDA Reform Bill Would Delay Guidance On Mobile Health Apps

The Senate user fee reauthorization and FDA reform bill, formally introduced May 15, includes several new provisions, including a moratorium on FDA issuing final guidance on mobile medical apps. The bill should see action on the Senate floor this week.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts